home | publications


1. Differences in Frequency of ERG Oncoprotein Expression Between Index Tumors of Caucasian and African American Patients With Prostate Cancer.
Philip Rosen, David Pfister, Denise Young, Gyorgy Petrovics, Yongmei Chen, Jennifer Cullen, Diana Böhm, Sven Perner, Albert Dobi, David G. McLeod, Isabell A. Sesterhenn, and Shiv Srivastava
Urology, 80 (4), 2012

2. Health-related Quality of Life for Men with Prostate Cancer—an Evaluation of Outcomes 12–24 Months After Treatment.
Stephen A. Brassell, M.D., Sally I. Elsamanoudi, M.P.H., Jennifer Cullen, Ph.D., Molly E. Williams, M.D., David G. McLeod, M.D., J.D.
Urologic Oncology, [Epub ahead of print] April 2012.

3. The Burden of Prostate Cancer in Asian Nations.
Jennifer Cullen, Sally Elsamanoudi, Stephen A. Brassell, Yongmei Chen, Monica Colombo, Amita Srivastava, and David G. McLeod
J Carcinog, 11: 7 [Epub ahead of print] March 2012.

4. TMPRSS2-Driven ERG Expression In Vivo Increases Self- Renewal and Maintains Expression in a Castration Resistant Subpopulation.
Orla M. Casey, Lei Fang, Paul G. Hynes, Wassim G. Abou-Kheir, Philip L. Martin, Heather S. Tillman, Gyorgy Petrovics, Hibah O. Awwad, Yvona Ward, Ross Lake, Luhua Zhang, Kathleen Kelly1
PLoS ONE, 7:7 [Epub ahead of print] July 2012.

5. Clinical Potential of the ERG Oncoprotein in Prostate Cancer.
Rosen P, Sesterhenn IA, Brassell S, McLeod DG, Srivastava S, Dobi A.
Nature Reviews Urology, Vol 9: 131-7, March 2012.

6. ERG Protein Expression and Genomic Rearrangement Status in Primary and Metastatic Prostate Cancer - a Comparative Study of Two Monoclonal Antibodies.
M Braun, D Goltz, Z Shaikhibrahim, W Vogel, D Bo¨hm, V Scheble, K Sotlar, F Fend, S-H Tan, A Dobi, G Kristiansen, N Wernert and S Perner
Prostate Cancer and Prostatic Diseases, 1-5, 2012

7. N-cadherin Expression in Testicular Germ Cell and Gonadal Stromal Tumors.
Heidenberg DJ, Barton JH, Young D, Grinkemeyer M, Sesterhenn IA
Journal of Cancer, 2012; 3:381-389

8. TMPRSS2- Driven ERG Expression In Vivo Increases Self-Renewal and Maintains Expression in a Castration Resistant Subpopulation.
Casey OM, Fang L, Hynes PG, Wassim AG, Martin PL, Tillman HS, Petrovics G, Awwad HO, Ward Y, Lake R, Zhang L, Kelly K
PLOS One, 2012, 7(7): e41668. doi:10.1371

9. Androgen dependent oncogenic activation of ETS transcription factors by recurrent gene fusions in prostate cancer: Biological and Clinical Implications (Book chapter).
Dobi A, Sreenath T, Srivastava S
Androgen-Responsive Genes in Prostate Cancer (Edited by Zhou Wang), Springer Edition, New York USA 2012